CIAM
IRWD icon

Caitong International Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Caitong International Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.83K Buy
+522
New +$2.14K ﹤0.01% 1259
2025
Q1 		– Sell
-627
Closed -$2.78K – 2351
2024
Q4 		$2.78K Buy
+627
New +$2.54K ﹤0.01% 1126

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Caitong International Asset Management's IRWD Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 522 shares worth $1.83K. The stake represents ﹤0.01% of the portfolio and ranks #1259 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in IRWD as recently as Q4 2024.

Caitong International Asset Management first reported a position in IRWD in Q4 2024 and has held it in 2 quarters since. The position peaked at $2.78K in Q4 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Caitong International Asset Management held 522 shares of Ironwood Pharmaceuticals worth $1.83K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new Caitong International Asset Management position in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1259 holding.
  • Caitong International Asset Management first reported a position in Ironwood Pharmaceuticals in Q4 2024 and has held it in 2 quarters since.
  • Caitong International Asset Management's Ironwood Pharmaceuticals position peaked at $2.78K in Q4 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.